TRUTRACE TECHNOLOGIES INC. Financials TruTrace Technologies Inc.
Equities
TTT
CA8984471075
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
Valuation
| Fiscal Period: April | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Capitalization 1 | 21.66 | 6.669 | 14.51 | 3.817 |
| Enterprise Value (EV) 1 | 20.49 | 6.899 | 13.61 | 4.498 |
| P/E ratio | -1.43 x | -1.42 x | -6.71 x | -1.64 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 2,16,55,18,300 x | 1,65,61,425 x | 8,92,67,132 x | 3,22,24,751 x |
| EV / Revenue | 2,04,91,96,400 x | 1,71,31,758 x | 8,37,73,009 x | 3,79,73,468 x |
| EV / EBITDA | -16,71,719 x | -15,54,472 x | -88,89,471 x | -21,55,457 x |
| EV / FCF | -51,72,362 x | -2,15,41,225 x | -99,16,623 x | -56,54,992 x |
| FCF Yield | -0% | -0% | -0% | -0% |
| Price to Book | 29.7 x | -2.6 x | -29.4 x | -1.51 x |
| Nbr of stocks (in thousands) | 80,204 | 83,362 | 1,52,694 | 1,52,694 |
| Reference price 2 | 0.2700 | 0.0800 | 0.0950 | 0.0250 |
| Announcement Date | 23/08/19 | 13/10/20 | 26/08/21 | 29/08/22 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: April | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net sales | - | 0.01 | 0.4027 | 0.1625 | 0.1185 |
| EBITDA | - | -12.26 | -4.438 | -1.531 | -2.087 |
| EBIT 1 | -1.257 | -12.26 | -4.444 | -1.536 | -2.09 |
| Operating Margin | - | -1,22,628.51% | -1,103.54% | -945% | -1,764.37% |
| Earnings before Tax (EBT) 1 | -1.267 | -14.77 | -4.639 | -1.621 | -2.335 |
| Net income 1 | -1.267 | -14.77 | -4.639 | -1.621 | -2.335 |
| Net margin | - | -1,47,731.69% | -1,152.08% | -997.47% | -1,970.71% |
| EPS 2 | -0.0402 | -0.1888 | -0.0564 | -0.0142 | -0.0153 |
| Free Cash Flow | - | -3.962 | -0.3203 | -1.373 | -0.7955 |
| FCF margin | - | -39,618.19% | -79.53% | -844.77% | -671.5% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 13/06/19 | 23/08/19 | 13/10/20 | 26/08/21 | 29/08/22 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: April | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 0.23 | - | 0.68 |
| Net Cash position 1 | 0.03 | 1.16 | - | 0.89 | - |
| Leverage (Debt/EBITDA) | - | - | -0.0517 x | - | -0.3263 x |
| Free Cash Flow | - | -3.96 | -0.32 | -1.37 | -0.8 |
| ROE (net income / shareholders' equity) | - | -3,803% | 504% | 106% | 155% |
| ROA (Net income/ Total Assets) | - | -1,004% | -382% | -126% | -169% |
| Assets 1 | - | 1.471 | 1.214 | 1.282 | 1.382 |
| Book Value Per Share 2 | 0 | 0.0100 | -0.0300 | -0 | -0.0200 |
| Cash Flow per Share 2 | 0 | 0.0100 | 0 | 0.0100 | 0 |
| Capex | - | 0.03 | - | - | - |
| Capex / Sales | - | 265.64% | - | - | - |
| Announcement Date | 13/06/19 | 23/08/19 | 13/10/20 | 26/08/21 | 29/08/22 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 6L | |
| +9.22% | 3.39TCr | |
| +21.99% | 835.06Cr | |
| +31.37% | 423.8Cr | |
| -30.15% | 267.31Cr | |
| -19.11% | 145.39Cr | |
| -28.03% | 132.5Cr | |
| -33.21% | 116.36Cr | |
| +13.85% | 100.33Cr | |
| -34.50% | 89Cr |
- Stock Market
- Equities
- TTT Stock
- Financials TruTrace Technologies Inc.